.
MergerLinks Header Logo

New Deal


Announced

Completed

Exponent Private Equity completed the acquisition of a 40% stake in Xeinadin Group.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For40%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

Private Equity

Management Consulting

Completed

Private

Acquisition

United Kingdom

Friendly

business advices

Domestic

Minority

Synopsis

Edit

Exponent Private Equity, a private equity firm, completed the acquisition of a 40% stake in Xeinadin Group, an accounting firm. Financial terms were not disclosed. “Xeinadin is one of the leading consolidators in the UK and Ireland professional services landscape and has a huge opportunity in a highly fragmented market. We’ve been impressed by the work done to date by Derry and the team to build a profitable business with highly diversified sources of income, more than 95% of which is recurring. We look forward to working with Xeinadin over the coming years,” Mark Taylor, Exponent Partner.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US